Health economic impact of Nerinetide in addition to mechanical thrombectomy without concurrent alteplase.

Johanna Maria OspelCorey AdamsMichael TymianskiMayank GoyalMichael Hill

Published in: Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences (2023)

Treating patients with a cerebroprotectant, such as Nerinetide, in addition to endovascular treatmentl in patients who cannot receive intravenous alteplase may be beneficial from a health-economic standpoint.

Keyphrases

public health
healthcare
mental health
acute ischemic stroke
health information
high dose
squamous cell carcinoma
human health
locally advanced
radiation therapy
social media
life cycle